Masayoshi Kukida Selected Research

Masayoshi Kukida Research Topics

Disease

4	Vascular System Injuries 01/2016 - 01/2015
3	Atherosclerosis 01/2021 - 10/2019
3	Cognitive Dysfunction 01/2018 - 04/2015
3	Vascular Remodeling 01/2016 - 01/2016
2	Abdominal Aortic Aneurysm 01/2021 - 01/2020
2	Neointima 01/2016 - 01/2016
1	Thoracic Aortic Aneurysm 10/2021
1	Aneurysm (Aneurysms) 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Chronic Renal Insufficiency 10/2019
1	Vascular Calcification 01/2019
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 11/2018
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2018
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 11/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Fibrosis (Cirrhosis) 10/2016
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2016
1	Obesity 01/2016
1	Hypercholesterolemia 01/2016
1	Binge-Eating Disorder (Binge Eating Disorder) 12/2015
1	Feeding and Eating Disorders (Eating Disorder) 12/2015
1	Body Weight (Weight, Body) 12/2015
1	Stroke (Strokes) 09/2015
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 04/2015
1	Inflammation (Inflammations) 01/2015
1	Essential Hypertension 01/2015
1	Hyperhomocysteinemia 07/2014
1	Kimura Disease 01/2014
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2014
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2012

Drug/Important Bio-Agent (IBA)

5	Type 2 Angiotensin ReceptorIBA 01/2019 - 04/2015
3	Angiotensin IIIBA 01/2021 - 01/2016
3	Polyethylene (Polythene)IBA 01/2016 - 01/2016
3	compound 21IBA 01/2016 - 04/2015
2	Angiotensin Receptor AntagonistsIBA 10/2021 - 09/2015
2	AngiotensinsIBA 01/2018 - 01/2016
2	EnzymesIBA 01/2018 - 01/2016
2	Immunoglobulin G (IgG)IBA 11/2016 - 01/2014
2	AntibodiesIBA 11/2016 - 01/2014
2	OsteopontinIBA 10/2016 - 01/2016
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016 - 01/2016
2	CytokinesIBA 01/2016 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2016
1	LigandsIBA 10/2021
1	Fibrillin-1IBA 10/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2020
1	Angiotensin IIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 10/2019
1	Adenine FDA LinkGeneric 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 11/2018
1	Angiotensin-Converting Enzyme 2IBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	HDL CholesterolIBA 11/2016
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 11/2016
1	Interleukin-18 (Interleukin 18)IBA 10/2016
1	AldosteroneIBA 10/2016
1	SaltsIBA 10/2016
1	LipidsIBA 01/2016
1	NAD (NADH)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 12/2015
1	sacubitril and valsartan sodium hydrate drug combinationIBA 09/2015
1	azilsartanIBA 04/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	HomocysteineIBA 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Phospholipase A2 ReceptorsIBA 01/2014
1	mizoribineIBA 01/2012
1	Inosine Monophosphate (IMP)IBA 01/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2012
1	Prednisolone (Predate)FDA LinkGeneric 01/2012

Therapy/Procedure

1	Therapeutics 11/2018
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2016